Key takeaways:
Metformin is often a first choice for the treatment of Type 2 diabetes.
Metformin has recently gained popularity for other possible health benefits, such as extending the lifespan. But these reported benefits aren’t supported by high-quality evidence.
Metformin’s role in preventing age-related diseases remains to be seen.
Metformin is one of the most commonly prescribed medications for Type 2 diabetes. It’s effective, safe, and well-tolerated. But more recently, people have been looking at metformin as more than just a medication to treat diabetes.
Metformin has gotten renewed attention for its possible use as an “anti-aging” medication. Some have even referred to it as a “wonder drug.”
Could metformin become one of the first anti-aging medications? Or is this just another health fad?
Metformin is a safe and effective medication used to help manage Type 2 diabetes. It comes from the French lilac, a plant used in Europe in the early 1900s as an herbal medicine to help manage blood sugar. Metformin has been FDA-approved to treat Type 2 diabetes since 1995.
Metformin is now one of the first-choice medications for Type 2 diabetes. It may also be used off-label to help lower someone’s risk for developing diabetes — for example, in people who have prediabetes or polycystic ovary syndrome (PCOS).
Metformin works by helping to stabilize and lower blood glucose (sugar) levels in the body. It does this a few different ways:
It decreases the amount of glucose the liver produces.
It decreases the amount of glucose the intestines absorb.
It makes the body’s tissues more sensitive to insulin. This makes the cells better able to absorb and use glucose in the blood.
Lowering blood glucose can have many health benefits. It can help keep someone’s weight in a healthy range, maintain a healthy blood pressure, and lower the risk of heart disease.
The research isn’t clear.
Based on early studies, researchers have asked whether metformin can slow aging, prevent age-related health conditions, and increase lifespan. This is based on research in which Metformin :
Has been shown to decrease the risk of age-related diseases in people with diabetes, including cancer and heart disease
Appears to improve metabolic markers in older adults including blood sugar, insulin levels, and DNA repair
Lowers inflammation, which we know plays a role in the aging process
Scientists don’t yet understand how metformin might affect the aging process in humans. They think it may have to do with how it lowers blood sugar levels, improves insulin sensitivity, and impacts the mitochondria in cells. Metformin may also mimic calorie restriction. This means lowering the number of calories you consume while still getting all of the necessary nutrients. Calorie restriction is one known way to increase lifespan in animal models.
There’s some observational evidence that suggests metformin may reduce the risk of stroke. But most of the available evidence shows it probably doesn’t. It might, however, help improve recovery after stroke.
The evidence is also mixed on whether or not metformin can protect the aging brain. This issue is difficult to tease out because metformin can cause vitamin B12 deficiency, and that deficiency can affect cognitive function.
Metformin isn’t currently recommended or approved for any age-related health conditions. But it’s actively being studied for this purpose.
Most of metformin’s studies have been in animal models. But there’s currently a large clinical trial called the TAME trial (Targeting Aging with Metformin) that’s studying metformin’s anti-aging effects. The trial is looking at adults between the ages of 65 and 79 to see if people taking metformin have delayed onset of age-related conditions like heart disease, dementia, and cancer.
The TAME trial hasn’t started yet and will run for 6 years once it begins. So, it’ll be quite some time before we have results.
Metformin is currently only FDA-approved for Type 2 diabetes. But off-label uses are common. This means a clinician will prescribe metformin for other conditions even though the FDA hasn’t approved it for those conditions. Off-label uses of metformin include:
Polycystic ovary syndrome (PCOS)
Gestational diabetes (diabetes during pregnancy)
Weight gain related to antipsychotic medications
Metformin has been referred to as a “miracle drug” because of some early findings in animal studies and small human studies showing that it may have some other benefits, including:
Protecting the heart
It’s important to keep in mind that these types of research studies have significant limitations, and they aren’t conclusive. So, we can’t say the same results would be seen in the general population. Larger and higher-quality studies are needed to confirm these benefits.
Metformin is a prescription medication with risks and side effects. These side effects and warnings are linked to metformin as a treatment for diabetes. But it’s difficult to say for sure what side effects are possible in people without diabetes, since there’s less research in this population. It should only be taken after a full discussion with your healthcare professional to make sure it’s right for you.
Metformin’s common side effects include:
Nausea or vomiting
Diarrhea
Gas or bloating
Stomach pain
Headache
Metformin has a boxed warning for a rare, yet life-threatening, condition called lactic acidosis. Using metformin long term can also lead to vitamin B12 deficiency and anemia. And metformin can interact with other medications including thyroid medications and certain diuretics or “water pills.”
If you have Type 2 diabetes or risk factors for developing diabetes, talk with your healthcare professional about metformin. It’s one of the most effective, safe, and commonly used medications for lowering blood sugar.
Metformin isn’t currently recommended for anti-aging benefits, and more research is needed. But it’s always a good idea to talk with your healthcare professional about what steps you can take to improve your health and age well. These steps may include exercising, eating a nutritious diet, and getting quality sleep.
Metformin is a first-choice medication for Type 2 diabetes. Some early research has suggested that metformin may have anti-aging benefits. But that doesn’t mean we should rush to start taking it. We don’t yet know if it’s safe for this purpose, or if it even truly increases lifespan in humans.
Like any medication, metformin has risks and side effects, and its use should be discussed with a healthcare professional.
American Federation for Aging Research. (n.d.). The TAME trial.
Bai, B., et al. (2021). Metformin: A novel weapon against inflammation. Frontiers in Pharmacology.
Bailey, C. J. (2017). Metformin: Historical overview. Diabetologia.
Campbell, J. M., et al. (2017). Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Research Review.
Chen, S., et al. (2022). Metformin in aging and aging-related diseases: Clinical applications and relevant mechanisms. Theranostics.
Cheng, Y. Y., et al. (2014). Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Journal of Stroke and Cerebrovascular Diseases.
Driver, C., et al. (2018). Cardioprotective effects of metformin. Journal of Cardiovascular Pharmacology.
ElSayed, N. A., et al. (2022). Pharmacologic approaches to glycemic treatment: Stands of care in diabetes – 2023. Diabetes Care.
Feng, J., et al. (2022). Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications. Pharmacological Research.
Goldberg, R. B., et al. (2022). Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation.
Kulkarni, A. S., et al. (2018). Metformin regulates metabolic and nonmetabolic pathways in skeletal muscles and subcutaneous adipose tissues of older adults. Aging Cell.
Madeo, F., et al. (2019). Caloric restriction mimetics against age-associated disease: Targets, mechanisms, and therapeutic potential. Cell Metabolism.
Martin-Montalvo, A., et al. (2013). Metformin improves healthspan and lifespan in mice. Nature Communications.
Mohammed, I., et al. (2021). A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Frontiers in Endocrinology.
Morales, D. R., et al. (2015). Metformin in cancer treatment and prevention. Annual Review of Medicine.
Most, J., et al. (2017). Calorie restriction in humans: An update. Ageing Research Reviews.
Sharma, S., et al. (2021). Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke. Life Sciences.
Syed, F. Z. (2019). Is metformin really a wonder drug? Annals of Internal Medicine.
Teede, H. J., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility.
Witters, L. A. (2001). The blooming of the French lilac. The Journal of Clinical Investigation.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.